Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Collegium to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Nov 12, 7:00AM CST

COLL : 29.70 (-2.43%)
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? Zacks Investment Research - Fri Nov 8, 8:36AM CST

Investors in Collegium Pharmaceutical, Inc. COLL need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $20 Put had some of the highest implied...

COLL : 29.70 (-2.43%)
Collegium Pharmaceutical: Q3 Earnings Snapshot AP - Thu Nov 7, 3:34PM CST

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 29.70 (-2.43%)
Collegium Reports Record Third Quarter 2024 Financial Results GlobeNewswire - Thu Nov 7, 3:02PM CST

COLL : 29.70 (-2.43%)
Collegium Appoints Vikram Karnani as Chief Executive Officer GlobeNewswire - Thu Nov 7, 3:01PM CST

COLL : 29.70 (-2.43%)
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy? Zacks Investment Research - Wed Nov 6, 6:58AM CST

Corcept Therapeutics Incorporated CORT has been having a fabulous 2024, with its share price increasing 60.5% year to date as of Nov. 5, 2024.This company engages in the discovery and development of drugs...

CORT : 51.40 (+0.49%)
COLL : 29.70 (-2.43%)
IONS : 35.63 (+0.11%)
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 GlobeNewswire - Thu Oct 24, 7:00AM CDT

COLL : 29.70 (-2.43%)
Collingwood Closes Private Placement ACCESSWIRE - Fri Oct 11, 12:00PM CDT

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 29.70 (-2.43%)
Collingwood Announces Non-Brokered Private Placement and Board Appointment ACCESSWIRE - Mon Sep 9, 12:02PM CDT

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 29.70 (-2.43%)
Collegium Pharmaceutical: Q2 Earnings Snapshot AP - Thu Aug 8, 3:20PM CDT

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 29.70 (-2.43%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025 Barchart - Sun Dec 22, 4:00PM CST
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot